Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts-Reference-Cited by-同舟云学术

Improved Risk Assessment by Integrating Molecular and Clinicopathological Factors in Early-stage Endometrial Cancer—Combined Analysis of the PORTEC Cohorts

Published:2016-03-22 Issue:16 Volume:22 Page:4215-4224
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Stelloo Ellen,Nout Remi A.,Osse Elisabeth M.,Jürgenliemk-Schulz Ina J.,Jobsen Jan J.,Lutgens Ludy C.,van der Steen-Banasik Elzbieta M.,Nijman Hans W.,Putter Hein,Bosse Tjalling,Creutzberg Carien L.,Smit Vincent T.H.B.M.

Funder

Dutch Cancer Society

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 600 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concurrent POLE hotspot mutations and mismatch repair deficiency/microsatellite instability in endometrial cancer: A challenge in molecular classification;Gynecologic Oncology;2024-12

2. Excellent concordance of the molecular classification between preoperative biopsy and final hysterectomy in endometrial carcinoma;Gynecologic Oncology;2024-11

3. Advanced endometrial cancer—The next generation of treatment: A society of gynecologic oncology journal club clinical commentary;Gynecologic Oncology Reports;2024-10

4. Molecular classification improves preoperative risk assessment of endometrial cancer;Gynecologic Oncology;2024-10

5. The impact of estrogen receptor and L1 cell adhesion molecule expression on endometrial cancer outcome correlates with clinicopathological risk group and molecular subgroup;Gynecologic Oncology;2024-10